| scholarly article | Q13442814 |
| P2093 | author name string | Zelenin AV | |
| Krayevsky AA | |||
| Akimov SS | |||
| Yegorov YE | |||
| Chernov DN | |||
| Bolsheva NL | |||
| P2860 | cites work | The effects of nucleoside analogs on telomerase and telomeres in Tetrahymena | Q34810908 |
| The two-stage mechanism controlling cellular senescence and immortalization | Q35236608 | ||
| Telomere loss: mitotic clock or genetic time bomb? | Q36706939 | ||
| Structure and function of telomeres | Q38763424 | ||
| DNA synthesis in the heterokaryons of non-dividing differentiated cells and culture cells with various proliferative potentials | Q42813937 | ||
| The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats | Q24339608 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Specific Association of Human Telomerase Activity with Immortal Cells and Cancer | Q27860801 | ||
| A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon | Q28639770 | ||
| Telomeres shorten during ageing of human fibroblasts | Q29547357 | ||
| A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis | Q29614741 | ||
| Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity | Q29615388 | ||
| Telomere length predicts replicative capacity of human fibroblasts | Q29615745 | ||
| Structure and function of telomeres | Q29615759 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 115-118 | |
| P577 | publication date | 1996-07-01 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Reverse transcriptase inhibitors suppress telomerase function and induce senescence-like processes in cultured mouse fibroblasts | |
| P478 | volume | 389 |
| Q36210474 | AZT as a telomerase inhibitor |
| Q34320727 | Biological timing and the clock metaphor: oscillatory and hourglass mechanisms |
| Q43549618 | Chronic in vitro exposure to 3'-azido-2', 3'-dideoxythymidine induces senescence and apoptosis and reduces tumorigenicity of metastatic mouse mammary tumor cells |
| Q77337873 | Clinical evaluation of biologically targeted drugs: Obstacles and opportunities |
| Q33945457 | DNA G-quadruplexes, telomere-specific proteins and telomere-associated enzymes as potential targets for new anticancer drugs |
| Q45035321 | Do Hormones, Telomere Lengths, and Oxidative Stress form an Integrated Phenotype? A Case Study in Free-Living Tree Swallows. |
| Q39262195 | Effect of targeted silencing of hTERT mRNA by lentivirus-mediated siRNA on A549 lung cancer cells in vitro |
| Q35964745 | Entecavir for the treatment of chronic hepatitis B. |
| Q30471962 | Euplotes Telomerase: Evidence for Limited Base-Pairing during Primer Elongation and dGTP as an Effector of Translocation |
| Q74014282 | Experimental research on ageing in Russia |
| Q38342698 | Identification of Determinants for Inhibitor Binding within the RNA Active Site of Human Telomerase Using PNA Scanning |
| Q73448811 | Influence of aging and cell senescence on telomerase activity in keratinocytes |
| Q43153047 | Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA. |
| Q73112617 | Inhibition of telomerase activity and cell proliferation by a reverse transcriptase inhibitor in gynaecological cancer cell lines |
| Q41679419 | Preclinical and clinical strategies for development of telomerase and telomere inhibitors |
| Q40938167 | Specific inhibition of human telomerase activity by transfection reagent, FuGENE6-antisense phosphorothioate oligonucleotide complex in HeLa cells |
| Q92495595 | Stilbene Compounds Inhibit Tumor Growth by the Induction of Cellular Senescence and the Inhibition of Telomerase Activity |
| Q38835615 | Structural Basis of Telomerase Inhibition by the Highly Specific BIBR1532 |
| Q33383955 | Targeting human telomerase for cancer therapeutics. |
| Q34241488 | Telomerase and oral cancer |
| Q28079188 | Telomerase as a Cancer Target. Development of New Molecules |
| Q34398134 | Telomerase in endocrine and endocrine-dependent tumors |
| Q50989022 | Telomerase inhibition may contribute to accelerated mitochondrial aging induced by anti-retroviral HIV treatment |
| Q37414350 | Telomerase structure paves the way for new cancer therapies. |
| Q33833328 | Telomerase. A target for anticancer therapy |
| Q73225074 | Telomeres, telomerase and HCC: the long and the short of it |
| Q39862376 | The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells |
| Q38311394 | The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis |
| Q77735185 | The telomerase challenge - an unusual problem in drug discovery |
| Q34655822 | Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology |
Search more.